|
[Related PubMed/MEDLINE] Total Number of Papers: 219
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: ASA |
Long Form |
: arylsulfatase A |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Long-Term Consequences of Increased Activity of Urine Enzymes After Cardiac Surgery - A Prospective Observational Study. |
AKI, CABG, CS, CSA-AKI, NAG |
2 |
2022 |
The Influence of Ambient Temperature Changes on the Indicators of Inflammation and Oxidative Damage in Blood after Submaximal Exercise. |
AAT, ACP, CTSD, CWI, IL-10, IL-1beta, IL-6, IL-8, TGF-beta1, TNF-alpha |
3 |
2022 |
[Lysosomal enzyme analysis of mucolipidosis type II alpha/beta and type III alpha/beta in two Chinese pedigrees]. |
GBA, GLA, GLB1, GUSB, IDUA, ML, NAGLU |
4 |
2021 |
Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice. |
FAAH, MLD |
5 |
2021 |
Novel disease-causing variants in a cohort of Iranian patients with metachromatic leukodystrophy and in silico analysis of their pathogenicity. |
MLD |
6 |
2021 |
The Effect of Submaximal Exercise Followed by Short-Term Cold-Water Immersion on the Inflammatory State in Healthy Recreational Athletes: A Cross-Over Study. |
AAT, ACP, CTSD, CWI, IL-10, IL-6, TGF-beta1, TNF-alpha |
7 |
2020 |
Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential. |
MLD, PD, SNCA |
8 |
2020 |
Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis. |
--- |
9 |
2020 |
Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy. |
--- |
10 |
2020 |
Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives. |
MLD, PD |
11 |
2020 |
Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study. |
MLD |
12 |
2020 |
Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients. |
MLD |
13 |
2020 |
River water irrigation with heavy metal load influences soil biological activities and risk factors. |
Er, FDA, MBC, NRA, PMN, RI, UA |
14 |
2020 |
Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial. |
CSF, EOW, MLD, SAEs |
15 |
2020 |
The Impact of Modern Therapeutic Methods on the Oxidant-Antioxidant Equilibrium and Activities of Selected Lysosomal Enzymes and Serine Protease Inhibitor in Amateur Athletes. |
AAT, ACP, CAT, CTSD, DEMS, GPx, SOD, TBARS, US |
16 |
2019 |
Metachromatic leukodystrophy: Characterization of two (p.Leu433Val, p.Gly449Arg) arylsulfatase A mutations. |
MLD |
17 |
2019 |
Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK-611) in Children With Metachromatic Leukodystrophy. |
CNS, CSF, MLD, PK |
18 |
2019 |
The impact of high-intensity laser therapy on oxidative stress, lysosomal enzymes, and protease inhibitor in athletes. |
AAT, ACP, CAT, CTSD, GPx, HILT, SOD |
19 |
2017 |
Activity of urine arylsulfatase A in brain‑dead graft donors is a predictor of early and late graft function. |
--- |
20 |
2017 |
Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A. |
BBB, CNS, ERT, LSD, MLD |
21 |
2016 |
Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations. |
CHO, MLD |
22 |
2016 |
The oxidant-antioxidant equilibrium, activities of selected lysosomal enzymes and activity of acute phase protein in peripheral blood of 18-year-old football players after aerobic cycle ergometer test combined with ice-water immersion or recovery at room temperature. |
AAT, ACP, CAT, CTSD, GPx, SOD |
23 |
2015 |
Activity of alpha1-antitrypsin and some lysosomal enzymes in the blood serum of patients with chronic obstructive pulmonary disease after smoking cessation. |
AAT, ACP, CTSD |
24 |
2015 |
Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population. |
ASA-PD, LD, MLD |
25 |
2015 |
Dysfunction of platelet-derived growth factor receptor alpha (PDGFRalpha) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells. |
NPs, OLs, PDGFRalpha |
26 |
2015 |
Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy. |
CNS, CRIM, CSF, MLD, NCS, SSEPs |
27 |
2014 |
Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation. |
MLD, PBCA |
28 |
2014 |
Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A. |
apoB, BBB, ERT, LSDs, Tat |
29 |
2014 |
Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector. |
BBB, GFP, LSD, MLD, SC, ssAAV9, Sulf |
30 |
2013 |
Developing therapeutic approaches for metachromatic leukodystrophy. |
BBB, MLD |
31 |
2013 |
Effects of open versus laparoscopic nephrectomy techniques on oxidative stress markers in patients with renal cell carcinoma. |
ACP, CAT, CTSD, GPx, SOD, TBARS |
32 |
2013 |
Fluorescent dye conjugates of rabbit arylsulfatase A as a biological tracer for protein endocytosis. |
--- |
33 |
2012 |
Brain MRI and biological diagnosis in five Tunisians MLD patients. |
MLD, MRI |
34 |
2012 |
Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age. |
ERT, HSCT, MLD, NCV |
35 |
2012 |
Novel patient cell-based HTS assay for identification of small molecules for a lysosomal storage disease. |
HTS, LSDs, MLD, pNC, pNCS, SV40t |
36 |
2012 |
Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor. |
BBB, HIR, mAb, MLD |
37 |
2012 |
Sperm arylsulfatase A binds to mZP2 and mZP3 glycoproteins in a nonenzymatic manner. |
ZP |
38 |
2011 |
Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression. |
ASA-PD, EDSS, MLD, MR, MS, MSSS |
39 |
2011 |
Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy. |
BBB, CNS, CSF, ERT, LSD, MLD, rhASA |
40 |
2011 |
Transport of arylsulfatase A across the blood-brain barrier in vitro. |
BBB |
41 |
2010 |
Metachromatic leukodystrophy--an update. |
MLD |
42 |
2010 |
Nitrogen fixation capacity of Azotobacter spp. strains isolated from soils in different ecosystems and relationship between them and the microbiological properties of soils. |
APA, BSR, CA, GA, UA |
43 |
2009 |
Automatic analysis of altered gait in arylsulphatase A-deficient mice in the open field. |
--- |
44 |
2009 |
Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. |
CNS, ERT, LSDs, MLD, PNS, rhASA |
45 |
2009 |
Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1. |
AAV1, GFP, i.t, MLD |
46 |
2009 |
Interaction of arylsulfatase-A (ASA) with its natural sulfoglycolipid substrates: a computational and site-directed mutagenesis study. |
SGC, SGG |
47 |
2009 |
Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy. |
Sap B |
48 |
2009 |
Site-specific analysis of N-linked oligosaccharides of recombinant lysosomal arylsulfatase A produced in different cell lines. |
ERT, MLD |
49 |
2008 |
Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy. |
MLD |
50 |
2008 |
Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells. |
--- |
51 |
2008 |
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. |
--- |
52 |
2008 |
Presence of arylsulfatase A and sulfogalactosylglycerolipid in mouse ovaries: localization to the corpus luteum. |
SGG |
53 |
2008 |
Sulfatide is required for efficient replication of influenza A virus. |
CGT, CST, HA, IAVs, mAb, NP |
54 |
2007 |
A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy. |
MLD |
55 |
2007 |
Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. |
MLD |
56 |
2007 |
Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy. |
ERT, hASA, MLD |
57 |
2007 |
Serum adenosine deaminase and arylsulphatase A as an index of early infiltration of central nervous system in acute lymphoblastic leukemia. |
ADA, ALL, CNS |
58 |
2007 |
Sperm surface arylsulfatase A can disperse the cumulus matrix of cumulus oocyte complexes. |
COCs |
59 |
2007 |
Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. |
CST |
60 |
2007 |
Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects. |
MLD, MS |
61 |
2007 |
The effect of whole-body cryostimulation on lysosomal enzyme activity in kayakers during training. |
ACP, CK, CTSD |
62 |
2007 |
The effects of heavy metal pollution on enzyme activities and basal soil respiration of roadside soils. |
APA, BSR, UA |
63 |
2006 |
AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy. |
AAV1, FGE, MLD |
64 |
2006 |
Carbohydrate affinity chromatography indicates that arylsulfatase-A from capacitated boar sperm has mannose and N-acetylglucosamine/sialic acid residues. |
Con A, RP |
65 |
2006 |
Ethanol decreases rat hepatic arylsulfatase A activity levels. |
--- |
66 |
2006 |
Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. |
HIV-ASA, MLD |
67 |
2006 |
In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. |
GMP, M6P, MSCs |
68 |
2006 |
Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. |
--- |
69 |
2006 |
Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene. |
--- |
70 |
2006 |
Reduced brain cholesterol content in arylsulfatase A-deficient mice. |
MLD |
71 |
2006 |
Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity. |
ASB, GAGs, IDS, STS |
72 |
2006 |
Sulfatide with short fatty acid dominates in astrocytes and neurons. |
--- |
73 |
2006 |
Tyrosine sulfation of arylsulfatase A and its peptide. |
--- |
74 |
2005 |
A novel mass spectrometric assay for the cerebroside sulfate activator protein (saposin B) and arylsulfatase A. |
--- |
75 |
2005 |
Changes of lysosomal enzymes activity in the skeletal muscle fibers exposed to endurance exercise. |
beta-GRS, NAG |
76 |
2005 |
Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy. |
FGE, MLD |
77 |
2005 |
Delay of myelin formation in arylsulphatase A-deficient mice. |
MBP, MLD, PLP |
78 |
2005 |
Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. |
ERT, PNS |
79 |
2005 |
Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer. |
GAGs, HS, HSPGs, IL-6, TAM |
80 |
2005 |
Gene therapy of metachromatic leukodystrophy. |
MLD |
81 |
2005 |
Human chronic fascioliasis: a possible cause of unexplained abnormal liver tests. |
ACP, ALP, AST, GGT, IHAT |
82 |
2005 |
Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum. |
ER |
83 |
2005 |
Peripheral neuropathy in metachromatic leucodystrophy. A study of 40 cases from south India. |
MLD |
84 |
2004 |
Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice. |
--- |
85 |
2004 |
ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs. |
ESE, MLD |
86 |
2004 |
Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer. |
IL-8, MIBC, SBC, TNF-alpha |
87 |
2004 |
Late onset MLD with normal nerve conduction associated with two novel missense mutations in the ASA gene. |
MLD |
88 |
2004 |
Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution. |
--- |
89 |
2004 |
Novel mutations associated with metachromatic leukodystrophy: phenotype and expression studies in nine Czech and Slovak patients. |
MLD |
90 |
2004 |
Rat sperm AS-A: subcellular localization in testis and epididymis and surface distribution in epididymal sperm. |
Cd, Co, CP, ER, IS |
91 |
2004 |
[Relationship between mycoplasma infection and germ cell sulfogalactosylglycerolipid]. |
SGG, UU |
92 |
2003 |
Acquisition of arylsulfatase A onto the mouse sperm surface during epididymal transit. |
--- |
93 |
2003 |
Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy. |
MLD, PD |
94 |
2002 |
Adult metachromatic leukodystrophy: three cases with normal nerve conduction velocities in a family. |
MLD, MRI |
95 |
2002 |
Allelic variation and environmental lead exposure in urban children. |
--- |
96 |
2002 |
Arylsulfatase a is present on the pig sperm surface and is involved in sperm-zona pellucida binding. |
ZP |
97 |
2002 |
Binding of arylsulfatase A to mouse sperm inhibits gamete interaction and induces the acrosome reaction. |
Ig, SGG |
98 |
2002 |
Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. |
MLD |
99 |
2002 |
Croatian population data for arylsulfatase a pseudodeficiency-associated mutations in healthy subjects, and in patients with Alzheimer-type dementia and Down syndrome. |
--- |
100 |
2002 |
Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy. |
--- |
|